Amicus Therapeutics 10K Form

Buy

63

FOLD
Amicus Therapeutics

Last Price:

11.17

Seasonality Move:

8.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09	10Q	FOLD/Amicus Therapeutics Quarterly
2023-11-08	10Q	FOLD/Amicus Therapeutics Quarterly
2023-08-08	10Q	FOLD/Amicus Therapeutics Quarterly
2023-05-10	10Q	FOLD/Amicus Therapeutics Quarterly
2022-11-07	10Q	FOLD/Amicus Therapeutics Quarterly
2022-08-04	10Q	FOLD/Amicus Therapeutics Quarterly

Receive FOLD News And Ratings

See the #1 stock for the next 7 days that we like better than FOLD

FOLD Financial Statistics

Sales & Book Value

Annual Sales:	$399.36M
Cash Flow:	$21.59M
Price / Cash Flow:	0
Annual Sales:	$0.45
Price / Book:	26.27

Profitability

EPS (TTM):	-0.39000
Net Income (TTM):	$-119.54M
Gross Margin:	$362.03M
Return on Equity:	-89.45%
Return on Assets:	-15.97%

Amicus Therapeutics Earnings Forecast

Key Amicus Therapeutics Financial Ratios

The Gross Profit Margin over the past 21 years for FOLD is 90.65%.
The Selling, General & Administrative Expenses for FOLD have been equal to 68.93% of Gross Profit Margin.
The Research & Development expenses have been 38.16% of Revenue.
The Interest Expense is -33.08% of Operating Income.
The Net Earning history of FOLD is -37.96% of Total Revenues.
Per Share Earnings over the last 21 years have been positive in 11 years.

Amicus Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	FOLD
CUSIP:	03152W
Website:	amicusrx.com

Debt

Debt-to-Equity Ratio:	2.93
Current Ratio:	2.75
Quick Ratio:	2.05

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	29.34

FOLD Technical Analysis vs Fundamental Analysis

Buy

63

Amicus Therapeutics (FOLD) is a Buy

Is Amicus Therapeutics a Buy or a Sell?

Amicus Therapeutics stock is rated a Buy
The current Amicus Therapeutics [FOLD] share price is $11.74. The Score for FOLD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.